nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—semen—acquired immunodeficiency syndrome	0.0487	0.143	CbGeAlD
Nandrolone decanoate—AR—semen—acquired immunodeficiency syndrome	0.0431	0.127	CbGeAlD
Nandrolone decanoate—Epididymitis—Delavirdine—acquired immunodeficiency syndrome	0.0261	0.0395	CcSEcCtD
Nandrolone decanoate—Epididymitis—Saquinavir—acquired immunodeficiency syndrome	0.0232	0.0352	CcSEcCtD
Nandrolone decanoate—MAOB—nerve—acquired immunodeficiency syndrome	0.0221	0.0649	CbGeAlD
Nandrolone decanoate—Hoarseness—Zidovudine—acquired immunodeficiency syndrome	0.0207	0.0314	CcSEcCtD
Nandrolone decanoate—MAOA—nerve—acquired immunodeficiency syndrome	0.0188	0.0554	CbGeAlD
Nandrolone decanoate—MAOB—blood plasma—acquired immunodeficiency syndrome	0.0167	0.0491	CbGeAlD
Nandrolone decanoate—Furunculosis—Ritonavir—acquired immunodeficiency syndrome	0.0167	0.0253	CcSEcCtD
Nandrolone decanoate—Local reaction—Zidovudine—acquired immunodeficiency syndrome	0.0165	0.0249	CcSEcCtD
Nandrolone decanoate—Furunculosis—Saquinavir—acquired immunodeficiency syndrome	0.016	0.0243	CcSEcCtD
Nandrolone decanoate—Hoarseness—Lamivudine—acquired immunodeficiency syndrome	0.0148	0.0224	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Nelfinavir—acquired immunodeficiency syndrome	0.0146	0.0221	CcSEcCtD
Nandrolone decanoate—Furuncle—Ritonavir—acquired immunodeficiency syndrome	0.0144	0.0219	CcSEcCtD
Nandrolone decanoate—MAOA—blood plasma—acquired immunodeficiency syndrome	0.0142	0.0419	CbGeAlD
Nandrolone decanoate—Furuncle—Saquinavir—acquired immunodeficiency syndrome	0.0139	0.0211	CcSEcCtD
Nandrolone decanoate—Acne—Stavudine—acquired immunodeficiency syndrome	0.0125	0.0189	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0124	0.0188	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0112	0.017	CcSEcCtD
Nandrolone decanoate—Dysphonia—Zidovudine—acquired immunodeficiency syndrome	0.0111	0.0168	CcSEcCtD
Nandrolone decanoate—Acne—Zidovudine—acquired immunodeficiency syndrome	0.0108	0.0164	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.0157	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Didanosine—acquired immunodeficiency syndrome	0.01	0.0152	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.01	0.0152	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Ritonavir—acquired immunodeficiency syndrome	0.00982	0.0149	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Stavudine—acquired immunodeficiency syndrome	0.00938	0.0142	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00871	0.0132	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Stavudine—acquired immunodeficiency syndrome	0.0087	0.0132	CcSEcCtD
Nandrolone decanoate—Fluid retention—Zidovudine—acquired immunodeficiency syndrome	0.00865	0.0131	CcSEcCtD
Nandrolone decanoate—Acne—Ritonavir—acquired immunodeficiency syndrome	0.00842	0.0128	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Zidovudine—acquired immunodeficiency syndrome	0.00815	0.0124	CcSEcCtD
Nandrolone decanoate—Acne—Saquinavir—acquired immunodeficiency syndrome	0.0081	0.0123	CcSEcCtD
Nandrolone decanoate—Dysphonia—Lamivudine—acquired immunodeficiency syndrome	0.0079	0.012	CcSEcCtD
Nandrolone decanoate—MAOA—retina—acquired immunodeficiency syndrome	0.0078	0.0229	CbGeAlD
Nandrolone decanoate—Acne—Lamivudine—acquired immunodeficiency syndrome	0.00773	0.0117	CcSEcCtD
Nandrolone decanoate—AR—skin of body—acquired immunodeficiency syndrome	0.00755	0.0222	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Efavirenz—acquired immunodeficiency syndrome	0.00716	0.0109	CcSEcCtD
Nandrolone decanoate—CYP19A1—blood—acquired immunodeficiency syndrome	0.0065	0.0191	CbGeAlD
Nandrolone decanoate—MAOB—digestive system—acquired immunodeficiency syndrome	0.00642	0.0189	CbGeAlD
Nandrolone decanoate—Irritability—Zidovudine—acquired immunodeficiency syndrome	0.00631	0.00957	CcSEcCtD
Nandrolone decanoate—MAOB—blood—acquired immunodeficiency syndrome	0.00612	0.018	CbGeAlD
Nandrolone decanoate—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.00612	0.018	CbGeAlD
Nandrolone decanoate—AR—digestive system—acquired immunodeficiency syndrome	0.00604	0.0177	CbGeAlD
Nandrolone decanoate—Libido decreased—Delavirdine—acquired immunodeficiency syndrome	0.00599	0.00909	CcSEcCtD
Nandrolone decanoate—Jaundice—Nevirapine—acquired immunodeficiency syndrome	0.00592	0.00897	CcSEcCtD
Nandrolone decanoate—MAOB—spinal cord—acquired immunodeficiency syndrome	0.00589	0.0173	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Lamivudine—acquired immunodeficiency syndrome	0.00582	0.00882	CcSEcCtD
Nandrolone decanoate—AR—blood—acquired immunodeficiency syndrome	0.00576	0.0169	CbGeAlD
Nandrolone decanoate—Jaundice—Nelfinavir—acquired immunodeficiency syndrome	0.00573	0.00869	CcSEcCtD
Nandrolone decanoate—Jaundice—Stavudine—acquired immunodeficiency syndrome	0.00571	0.00866	CcSEcCtD
Nandrolone decanoate—MAOB—vagina—acquired immunodeficiency syndrome	0.00567	0.0167	CbGeAlD
Nandrolone decanoate—AR—spinal cord—acquired immunodeficiency syndrome	0.00554	0.0163	CbGeAlD
Nandrolone decanoate—Libido decreased—Ritonavir—acquired immunodeficiency syndrome	0.00554	0.0084	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Delavirdine—acquired immunodeficiency syndrome	0.00551	0.00836	CcSEcCtD
Nandrolone decanoate—MAOA—digestive system—acquired immunodeficiency syndrome	0.00548	0.0161	CbGeAlD
Nandrolone decanoate—MAOB—lung—acquired immunodeficiency syndrome	0.00536	0.0158	CbGeAlD
Nandrolone decanoate—Libido decreased—Saquinavir—acquired immunodeficiency syndrome	0.00534	0.00809	CcSEcCtD
Nandrolone decanoate—AR—vagina—acquired immunodeficiency syndrome	0.00533	0.0157	CbGeAlD
Nandrolone decanoate—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.00528	0.0155	CbGeAlD
Nandrolone decanoate—MAOA—blood—acquired immunodeficiency syndrome	0.00522	0.0153	CbGeAlD
Nandrolone decanoate—Disturbance in sexual arousal—Ritonavir—acquired immunodeficiency syndrome	0.0051	0.00773	CcSEcCtD
Nandrolone decanoate—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.00508	0.0149	CbGeAlD
Nandrolone decanoate—AR—lung—acquired immunodeficiency syndrome	0.00505	0.0148	CbGeAlD
Nandrolone decanoate—MAOA—spinal cord—acquired immunodeficiency syndrome	0.00503	0.0148	CbGeAlD
Nandrolone decanoate—MAOB—nervous system—acquired immunodeficiency syndrome	0.00497	0.0146	CbGeAlD
Nandrolone decanoate—Jaundice—Zidovudine—acquired immunodeficiency syndrome	0.00497	0.00753	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Saquinavir—acquired immunodeficiency syndrome	0.00491	0.00744	CcSEcCtD
Nandrolone decanoate—MAOA—vagina—acquired immunodeficiency syndrome	0.00484	0.0142	CbGeAlD
Nandrolone decanoate—MAOB—central nervous system—acquired immunodeficiency syndrome	0.00478	0.014	CbGeAlD
Nandrolone decanoate—Irritability—Saquinavir—acquired immunodeficiency syndrome	0.00472	0.00716	CcSEcCtD
Nandrolone decanoate—AR—nervous system—acquired immunodeficiency syndrome	0.00467	0.0137	CbGeAlD
Nandrolone decanoate—Jaundice—Indinavir—acquired immunodeficiency syndrome	0.00462	0.007	CcSEcCtD
Nandrolone decanoate—MAOA—lung—acquired immunodeficiency syndrome	0.00458	0.0134	CbGeAlD
Nandrolone decanoate—AR—central nervous system—acquired immunodeficiency syndrome	0.0045	0.0132	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Delavirdine—acquired immunodeficiency syndrome	0.00442	0.00671	CcSEcCtD
Nandrolone decanoate—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.00436	0.00662	CcSEcCtD
Nandrolone decanoate—MAOA—nervous system—acquired immunodeficiency syndrome	0.00424	0.0124	CbGeAlD
Nandrolone decanoate—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.00418	0.00633	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00412	0.00625	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Ritonavir—acquired immunodeficiency syndrome	0.00409	0.0062	CcSEcCtD
Nandrolone decanoate—MAOA—central nervous system—acquired immunodeficiency syndrome	0.00408	0.012	CbGeAlD
Nandrolone decanoate—CYP19A1—brain—acquired immunodeficiency syndrome	0.00403	0.0118	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Saquinavir—acquired immunodeficiency syndrome	0.00394	0.00597	CcSEcCtD
Nandrolone decanoate—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.0039	0.0115	CbGeAlD
Nandrolone decanoate—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00387	0.00587	CcSEcCtD
Nandrolone decanoate—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00386	0.00585	CcSEcCtD
Nandrolone decanoate—MAOB—brain—acquired immunodeficiency syndrome	0.0038	0.0112	CbGeAlD
Nandrolone decanoate—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00375	0.00569	CcSEcCtD
Nandrolone decanoate—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00372	0.00563	CcSEcCtD
Nandrolone decanoate—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00368	0.00558	CcSEcCtD
Nandrolone decanoate—MAOB—lymph node—acquired immunodeficiency syndrome	0.00367	0.0108	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00362	0.00549	CcSEcCtD
Nandrolone decanoate—AR—brain—acquired immunodeficiency syndrome	0.00357	0.0105	CbGeAlD
Nandrolone decanoate—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00355	0.00538	CcSEcCtD
Nandrolone decanoate—AR—lymph node—acquired immunodeficiency syndrome	0.00345	0.0101	CbGeAlD
Nandrolone decanoate—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00334	0.00507	CcSEcCtD
Nandrolone decanoate—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00325	0.00493	CcSEcCtD
Nandrolone decanoate—MAOA—brain—acquired immunodeficiency syndrome	0.00324	0.00952	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0032	0.00486	CcSEcCtD
Nandrolone decanoate—MAOA—lymph node—acquired immunodeficiency syndrome	0.00313	0.00919	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00308	0.00468	CcSEcCtD
Nandrolone decanoate—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00308	0.00466	CcSEcCtD
Nandrolone decanoate—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00305	0.00462	CcSEcCtD
Nandrolone decanoate—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00302	0.00458	CcSEcCtD
Nandrolone decanoate—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00302	0.00458	CcSEcCtD
Nandrolone decanoate—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00298	0.00452	CcSEcCtD
Nandrolone decanoate—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00298	0.00452	CcSEcCtD
Nandrolone decanoate—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00298	0.00451	CcSEcCtD
Nandrolone decanoate—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00297	0.0045	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00294	0.00446	CcSEcCtD
Nandrolone decanoate—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00293	0.00444	CcSEcCtD
Nandrolone decanoate—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00289	0.00438	CcSEcCtD
Nandrolone decanoate—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00281	0.00425	CcSEcCtD
Nandrolone decanoate—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00274	0.00415	CcSEcCtD
Nandrolone decanoate—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00273	0.00414	CcSEcCtD
Nandrolone decanoate—Rash—Didanosine—acquired immunodeficiency syndrome	0.00272	0.00412	CcSEcCtD
Nandrolone decanoate—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00271	0.00411	CcSEcCtD
Nandrolone decanoate—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00267	0.00405	CcSEcCtD
Nandrolone decanoate—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00265	0.00402	CcSEcCtD
Nandrolone decanoate—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00265	0.00401	CcSEcCtD
Nandrolone decanoate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00261	0.00395	CcSEcCtD
Nandrolone decanoate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00258	0.00391	CcSEcCtD
Nandrolone decanoate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00257	0.0039	CcSEcCtD
Nandrolone decanoate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00256	0.00388	CcSEcCtD
Nandrolone decanoate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00253	0.00383	CcSEcCtD
Nandrolone decanoate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00244	0.0037	CcSEcCtD
Nandrolone decanoate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00244	0.0037	CcSEcCtD
Nandrolone decanoate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00243	0.00369	CcSEcCtD
Nandrolone decanoate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0024	0.00364	CcSEcCtD
Nandrolone decanoate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00236	0.00358	CcSEcCtD
Nandrolone decanoate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00236	0.00358	CcSEcCtD
Nandrolone decanoate—Rash—Stavudine—acquired immunodeficiency syndrome	0.00236	0.00357	CcSEcCtD
Nandrolone decanoate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00236	0.00357	CcSEcCtD
Nandrolone decanoate—Rash—Abacavir—acquired immunodeficiency syndrome	0.00232	0.00352	CcSEcCtD
Nandrolone decanoate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00232	0.00352	CcSEcCtD
Nandrolone decanoate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00232	0.00352	CcSEcCtD
Nandrolone decanoate—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.0023	0.00349	CcSEcCtD
Nandrolone decanoate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0023	0.00349	CcSEcCtD
Nandrolone decanoate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00227	0.00344	CcSEcCtD
Nandrolone decanoate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00338	CcSEcCtD
Nandrolone decanoate—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00337	CcSEcCtD
Nandrolone decanoate—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00332	CcSEcCtD
Nandrolone decanoate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00217	0.00329	CcSEcCtD
Nandrolone decanoate—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00214	0.00324	CcSEcCtD
Nandrolone decanoate—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00205	0.00311	CcSEcCtD
Nandrolone decanoate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00205	0.0031	CcSEcCtD
Nandrolone decanoate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00202	0.00306	CcSEcCtD
Nandrolone decanoate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00201	0.00304	CcSEcCtD
Nandrolone decanoate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.00293	CcSEcCtD
Nandrolone decanoate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00193	0.00293	CcSEcCtD
Nandrolone decanoate—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00293	CcSEcCtD
Nandrolone decanoate—Rash—Indinavir—acquired immunodeficiency syndrome	0.00191	0.00289	CcSEcCtD
Nandrolone decanoate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0019	0.00289	CcSEcCtD
Nandrolone decanoate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.00279	CcSEcCtD
Nandrolone decanoate—Rash—Efavirenz—acquired immunodeficiency syndrome	0.0018	0.00273	CcSEcCtD
Nandrolone decanoate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.0018	0.00273	CcSEcCtD
Nandrolone decanoate—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00272	CcSEcCtD
Nandrolone decanoate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00179	0.00271	CcSEcCtD
Nandrolone decanoate—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00172	0.00261	CcSEcCtD
Nandrolone decanoate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00172	0.00261	CcSEcCtD
Nandrolone decanoate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.00261	CcSEcCtD
Nandrolone decanoate—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00257	CcSEcCtD
Nandrolone decanoate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00164	0.00249	CcSEcCtD
Nandrolone decanoate—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00246	CcSEcCtD
Nandrolone decanoate—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00159	0.00242	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00159	0.00241	CcSEcCtD
Nandrolone decanoate—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00232	CcSEcCtD
Nandrolone decanoate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00232	CcSEcCtD
Nandrolone decanoate—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00228	CcSEcCtD
Nandrolone decanoate—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00146	0.00222	CcSEcCtD
Nandrolone decanoate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00146	0.00222	CcSEcCtD
Nandrolone decanoate—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00219	CcSEcCtD
Nandrolone decanoate—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00209	CcSEcCtD
